Patient Guide: A Study to Learn More About How Safe Darolutamide is and How Well it Works Under Real World Conditions When Taken in Addition to Standard Androgen Deprivation Therapy (ADT) in Indian Participants With High-risk Non-metastatic Castration-resistant Prostate Cancer (nmCRPC)

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 25 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT05348876
Status: 🟢 Enrolling Now
Condition: Non-metastatic Castration-resistant Prostate Cancer
Phase: PHASE4

Where You Can Participate

This study is available at 25 locations across the country.

Top locations include:
  • • Hyderabad, Andhra Pradesh
  • • Hyderabad, Andhra Pradesh
  • • Vijayawada, Andhra Pradesh
  • • And 22 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study to Learn More About How Safe Darolutamide is and How Well it Works Under Real World Conditions When Taken in Addition to Standard Androgen Deprivation Therapy (ADT) in Indian Participants With High-risk Non-metastatic Castration-resistant Prostate Cancer (nmCRPC) - Join Clinical Trial NCTNCT05348876

How to Join This Clinical Trial - NCTNCT05348876

Learn how to participate in this PHASE4 trial studying an investigational therapy for Non-metastatic Castration-resistant Prostate Cancer. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Non-metastatic Castration-resistant Prostate Cancer. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Non-metastatic Castration-resistant Prostate Cancer
Treatment Being Tested
Investigational treatment
Study Phase
PHASE4 - Research study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT05348876 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 25 locations. Find a study site near you:

Clinical Research Site

Hyderabad, Andhra Pradesh 500 004 - India

Status: TERMINATED

Clinical Research Site

Hyderabad, Andhra Pradesh 500096 - India

Status: COMPLETED

Clinical Research Site

Vijayawada, Andhra Pradesh 520004 - India

Status: TERMINATED

Clinical Research Site

Visakhapatnam, Andhra Pradesh - India

Status: TERMINATED

Clinical Research Site

Nadiād, Gujarat 387001 - India

Status: COMPLETED

Clinical Research Site

Surat, Gujarat 395002 - India

Status: TERMINATED

Clinical Research Site

Belagavi, Karnataka 590010 - India

Status: WITHDRAWN

Clinical Research Site

Bengaluru, Karnataka 560027 - India

Status: COMPLETED

Clinical Research Site

Bengaluru, Karnataka 560076 - India

Status: TERMINATED

Clinical Research Site

New Delhi, Karnataka 110 085 - India

Status: RECRUITING

And 15 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE4 clinical trial for Non-metastatic Castration-resistant Prostate Cancer:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships